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On a broader note, Dr Noel highlights a point with
which we could not agree with more: national self-
sufficiency in organ transplantation is needed to
combat organ tourism and achieve global justice in
transplantation. As the Declaration of Istanbul on Organ
Trafficking and Transplant Tourism suggests, national
governments have a responsibility to monitor their
transplant activity, prohibiting unethical transplant
practices.3
1. No¨el L. The data on transplantation in Saudi Arabia are complex
and require additional framework for interpretation. Kidney Int 2009;
76: 914.
2. Horvat LD, Shariff SZ, Garg AX. Global trends in the rates of living kidney
donation. Kidney Int 2009; 75: 1088–1098.
3. International Summit on Transplant Tourism and Organ Trafficking. The
Declaration of Istanbul on Organ Trafficking and Transplant Tourism. Clin
J Am Soc Nephrol 2008; 3: 1227–1231.
Lucy D. Horvat1,2 and Amit X. Garg1,2
1Division of Nephrology, Department of Medicine, University of Western
Ontario, London, Canada and 2London Kidney Clinical Research Unit,
Department of Epidemiology and Biostatistics, University of Western Ontario,
London, Canada
Correspondence: Amit X. Garg, London Kidney Clinical Research Unit,
Department of Epidemiology and Biostatistics, London Health Sciences
Centre, University of Western Ontario, Room ELL-101,
Westminster Tower, 800 Commissioners Road East, London, Ontario,
Canada N6A 4G5. E-mail: amit.garg@lhsc.on.ca
Mineral complexes and vascular
calcification
Kidney International (2009) 76, 915; doi:10.1038/ki.2009.273
To the Editor: Matsui et al.1 have nicely demonstrated
a fetuin-containing mineral complex in adenine-treated rats
with renal failure that is prevented by alendronate treatment.
However, the conclusion that this is related to, or is a marker
of vascular calcification is premature. The presence of this
complex is not surprising considering the extremely high
circulating phosphate levels that occur in this model. In
addition, the failure to control pH during the preparation of
the serum almost certainly increased these complexes because
of the reduced solubility in alkaline solution. We routinely
dilute our plasma samples immediately after they are
obtained in order to prevent precipitation of calcium and
phosphate. The absence of the complexes in alendronate-
treated rats can easily be explained by the significantly lower
calcium concentration, which, as was shown by the authors,
has a major impact on complex formation. The inhibition of
vascular calcification is probably due to a direct inhibition as
we have shown for bisphosphonates in cultured aortas.2 The
formation of the mineral complexes is probably just a
physicochemical phenomenon related to ambient phosphate
and calcium levels. Their correlation with vascular calcifica-
tion can be explained by the fact that calcium and phosphate
levels also affect vascular calcification, rather than by a direct
pathophysiological link.
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We previously showed that serum fetuin-A concentra-
tions were not significantly associated with coronary artery
calcification scores in diabetic chronic kidney disease
patients.2 Therefore, we tried to elucidate whether low
serum fetuin-A levels really correlate with vascular
calcification in animal models. Renal failure model rats
showed that not serum fetuin-A concentrations but
fetuin–mineral complex (FMC) correlated with the extent
of vascular calcification.3 This complex was not observed
in rats without vascular calcification. As we only found the
association between FMC and vascular calcification in rats
with adenine-induced renal failure, further investigation
must be carried out to assert that FMC is a marker of
vascular calcification stress.
Serum pH levels might affect FMC formation. As we did
not control pH during serum preparation,3 we measured
the pH of residual serum samples. Serum pH was
7.762±0.119 in control rats, 7.691±0.088 in adenine rats
at 2 weeks, 7.583±0.045 at 4 weeks, and 7.614±0.062 at 5
weeks. Although the addition of 1M Tris-HCl (pH 7.2) to
these serum samples decreased pH, we found similar FMC
in pH-modified adenine rat serum (data not shown). This
preliminary result suggests that FMC can exist in serum
without alkalemia.
We showed that injection of alendronate to adenine rats
reduced FMC, followed by the inhibition of vascular
calcification. Lomashvili et al.4 demonstrated well the
mechanism by which bisphosphonates prevent medial
vascular calcification. They showed that etidronate and
pamidronate can directly inhibit vascular calcification
independent of bone resorption.4 It is possible that
alendronate also directly functioned in our model.
However, the changes in serum/plasma calcium levels by
bisphosphonate administration suggest another mechan-
ism. Alendronate decreased serum calcium in our experi-
ment, but etidronate and pamidronate did not in
Lomashvili’s experiments,4 except for the highest etidro-
nate group. This difference may indicate that bone
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